期刊文献+

透明细胞肾细胞癌中VEGF、Ki-67的表达及其相关性分析 被引量:4

Correlation between expression of VEGF and Ki-67 in clear cell renal cell cancer
下载PDF
导出
摘要 目的:探讨VEGF和Ki-67在透明细胞肾细胞癌(ccRCC)中的表达及其相互关系。方法:采用免疫组化SP法检测64例ccRCC组织中VEGF和Ki-67的表达,同时选取15例正常肾组织作为正常对照。结果:CcRCC组织中VEGF、Ki-67阳性表达率分别为71.88%(46/64)、53.13%(34/64),而正常肾组织分别为26.67%(5/15)、13.33%(2/15),差异均有统计学意义。VEGF和Ki-67的阳性表达率与临床分期、Furhman分级及淋巴转移密切相关,而与患者性别、年龄无明显相关。VEGF与Ki-67的表达呈正相关。结论:VEGF和Ki-67与ccRCC的发生、发展及预后密切相关,两者检测对ccRCC术后治疗和预后有一定的指导意义。 Objective: To explore the expression and correlation between VEGF and Ki-67 in clear cell renal cell cancer(ccRCC).Methods: Surgical specimens in paraffin of 64 cases of renal clear cell carcinoma and 15 cases of normal renal tissue were collected.The protein expression of VEGF and Ki-67 were detected by immunohistochemical SP method.Results: The expression levels of VEGF and Ki-67 protein in ccRCC were significantly higher than those in normal renal tissue.The expression of VEGF and Ki-67 were closely correlated with clinical stages,Furhman grade and lymph node metastasis,but were not with age and gender.The expressions of VEGF and Ki-67 had a significant positive correlation.Conclusion: VEGF and Ki-67 may play an important roles in carcinogenesis of ccRCC.Combined detection of the expression of VEGF and Ki-67 is helpful to know the biological hehavior of ccRCC and to estimate the prognosis and the treatment of patients.
出处 《陕西医学杂志》 CAS 2012年第11期1447-1449,共3页 Shaanxi Medical Journal
基金 福建省卫生厅青年科研课题资助(NO.39135)
关键词 肾肿瘤 病理学 血管内皮生长因子 @Ki-67 免疫组织化学 腺癌 透明细胞 Kidney neoplasms/pathology Vascular endothe lial growth factors @GF Ki-67 Immunohistochemistry Adenocarcinoma clear cell
  • 相关文献

参考文献7

  • 1谈宜傲,周林玉,石结武,郝天春,王子夜,田超,张旗.CXCR4在肾透明细胞癌组织中的表达及意义[J].山东医药,2011,51(11):29-30. 被引量:5
  • 2Uzzo RG. Cherullo EE, Myles J, etal. Renal cell carci- noma invading the urinary collecting system: implications for staging. J Urol. 2002, 167(6):2392 -2396.
  • 3Daniel Vallb(:~hmer MD, Jeffrey H. Peters MD, et al. Molecular determinant in targeted therapy for esophgeal adenocarcinoma [J].Arch Surg, 2006, 141(5): 476- 482.
  • 4Pourgholami MH, Morris DI.. Inhibitors of vascular en- dothelial growth factor in cancer[J]. Cardiovasc Hematol Agents Med Chem, 2008, 6(4): 343-347.
  • 5Des Guetz G, Uzzan B, Nicolas P, et al. Mierovessel den sity and VEGF expression are prognostic factors in color eetal cancer, recta-analysis of the literature[J]. Br J Cane er,2006,94(12) : 1823-1832.
  • 6陈燕.Her-2和Ki-67在结肠癌中的表达及其意义[J].临床军医杂志,2009,37(5):787-789. 被引量:9
  • 7张鲁东,李延江,骆磊,鲁友谊.Ki-67和VEGF在肾细胞癌中的表达及意义[J].临床军医杂志,2009,37(6):975-977. 被引量:2

二级参考文献28

  • 1高凤兰.直肠癌C-erbB-2、nm23蛋白表达与预后的关系[J].世界华人消化杂志,2006,14(10):1015-1018. 被引量:7
  • 2胡敬群,王占华,蒋扬富,李申德.p53基因和HER-2/neu p185基因表达与结肠癌的预后[J].中华肿瘤杂志,1996,18(4):247-249. 被引量:10
  • 3Arteaga CL, Moulder SL, Yakes FM. HER (erb)B) tyrosine kinase inhibitors in the treatment of breasl cancer[J]. Semin Oncol, 2002,29(11) : 4 - 10.
  • 4Raxevanis CN, Sotiropoulou PA, Sotiriadou NN, et al. Immunobiology of IIER-2/neu oneoprotein and its potential application in cancer immunotherapy[ J ]. Cancer Immunol Immunother, 2004, 53(3): 166 - 175.
  • 5Kapitanovic S, Radoscvic S, Kapitanovic M, et al.The expression of p185 (HER-2/neu) corrclates with the stage of diseasc and survival in colorectal cancer [ J ], Castroenterology, 1997, 112(4) :1103 -1113.
  • 6Gerdes J,Lemke H,Baisch H,et al.Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoelonal antibody Ki67[J].J Immunol,1994,133(1):710-716.
  • 7Urruticoechca A, Smith IE, Dowsett M, et al. Proliferation marker Ki-67 in early breast cancer [ J ]. J Clin Oncol, 2005.23 (28) : 7212 - 7220.
  • 8Kuniyasu H,Ove N, Shiqeishi,et al. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis[ J ]. J Exp Clin Cancer Res, 2001,20 (4) :543 -548.
  • 9Cerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with cell proliferation [ J ]. Int J Cancer, 1983, 31(1):13- 20.
  • 10Schluter C, Duchrow M, Wohlenberg C, et al. The cell proliferation associated antigen protein with numerous repeated elements. representing a new kind of ceil cycle maintaining proteins[ J]. J Cell Biol, 1993, 123(3) :513.

共引文献13

同被引文献36

  • 1孙乃英,孙明强,戴淑玲,周立.C-erbB-2、ER、PR在子宫内膜癌中的表达及其临床意义[J].中国医药导报,2007,4(06X):19-20. 被引量:7
  • 2Shih HC,Shiozawa T,Kato K,et al.Immunohistochemical expression of cyclins,cyclin-dependent kinases,tumor-suppressor gene products.Ki-67,and sex steroid receptors in endometrial carcinoma:positive staining for cyclin A as a poor prognostic indicator[J].Hum Pathol,2003,34(5):471-478.
  • 3Fanning J,Brown S,Phibbs G,et al.Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer[J].Int J Gynecol Cancer,2002,12(3):286-289.
  • 4Lax SF,Pizer ES,Ronnett BM,et al.Comparison of estrogen and progesterone receptor,Ki-67,and p53immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous,mucinous,secretory,and ciliated cell differentiation[J].Hum Pathol,1998,29(9):924-931.
  • 5Stefansson IM,Salvesen HB,Immervoll H,et al.Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type[J].Histopathology,2004,44(5):472-479.
  • 6Nielsen AL,Nyholm HC.The combination of p53and age predict cancer specific death in advanced stage(FIGO Ic-IV)of endometrial carcinoma of endometrioid type.An immunohistochemical examination of growth fraction:Ki-67,MIB-1and PC10;suppressor oncogene protein:p53;oncogene protein:p185 and age,hormone treatment,stage,and histologic grade[J].Eur J Obstet Gynecol Reprod Biol,1996,70(1):79-85.
  • 7Siegel R, Ma J, Zou Z, et al. Cancer statistics [J]. CA Cancer J Clin, 2014,64 : 9-29.
  • 8Peeorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium [J]. Int J Gynaecol Obstet, 2009, 105 (2) : 103-104.
  • 9Kizer NT, Gao F, Guntupalli S, et al. Lower uterine segment in- volvement is associated with poor outcomes in early-stage endo- metrioid endometrial carcinoma [J]. Ann Surg Oncol, 20I 1,18 (5) : 1419-1424.
  • 10Athanassiadou P, Athanassiades P, Grapsa D, et al. The prognos- tic value of PTEN, p53, and beta-catenin in endometrial carci- noma: a prospective immunocytochemical study [J]. Gynecol Cancer, 2007,17 (3) : 697-704.

引证文献4

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部